Showing results (411-420 of 433) with videos related to

Sort By:
Pageof 44
Biomaterials|May 26, 2005
Real-time 3-D dark-field microscopy for the validation of the cross-linking process of alginate microcapsulesR Wolf, D Zimmermann, M Weber, et al.
The Lancet. Oncology|February 21, 2012
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trialLuis Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerLuis G Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Journal of Molecular and Cellular Cardiology|December 7, 2018
Mechanistic role of the CREB-regulated transcription coactivator 1 in cardiac hypertrophyKaroline Morhenn, Thomas Quentin, Helen Wichmann, et al.
NPJ Parkinson'S Disease|May 29, 2023
Combining skin and olfactory α-synuclein seed amplification assays (SAA)-towards biomarker-driven phenotyping in synucleinopathiesA Kuzkina, J Rößle, A Seger, et al.
Plos One|November 13, 2012
Impact of AT2 receptor deficiency on postnatal cardiovascular developmentDaniel Biermann, Andreas Heilmann, Michael Didié, et al.
JCI Insight|October 18, 2019
Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafishMartina S Burczyk, Martin D Burkhalter, Teresa Casar Tena, et al.
Circulation Research|August 21, 2015
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction ModelJohannes Riegler, Malte Tiburcy, Antje Ebert, et al.
Journal of Materials Science. Materials in Medicine|June 2, 2005
Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantationH Zimmermann, D Zimmermann, R Reuss, et al.
British Journal of Clinical Pharmacology|January 14, 2022
Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapyRonald de Wit, Thomas Powles, Daniel Castellano, et al.
Pageof 44